LAB

0.60191.92%
SM

Sean Mackay

Senior VP & Chief Business Officer

Mr. Sean Mackay serves as Director at Abbratech, Inc. He served as a Operating Partner and Portfolio Advisor at Casdin Capital, LLC since 2023 till November 2024. He is Co-Founder of IsoPlexis Corp. and serves as its Chief Executive Officer and Director since 2014. He served as the President of IsoPlexis Corp since 2014. He serves as a Director of AbbraTech Holdings LLC. He serves as Senior Vice President and Chief Business Officer at Standard BioTools Inc since May 20, 2024. Mr. Mackay is an experienced entrepreneur at the convergence of life sciences and healthcare delivery. He leads IsoPlexis. He led IsoPlexis through foundational licensing and capital raising, while building the team and developing applications and product. Previously, he advanced business development at Kleiner Perkins-backed and incubated Lifesquare, which connected patients, payers and providers through sharing essential healthcare information. While at Lifesquare, he generated strategic initiatives related to partnerships across the healthcare ecosystem. Through work at Lazard and several early-stage ventures, he developed deep experience in structuring and financing life sciences companies. He advised multiple biotechnology and medical technology companies on how to manage times of strategic change. He founded life science-focused debt advisory business line at Lazard, helping grow revenues ten-fold for the group and establishing infrastructure and hiring required to sustain the business. Mr. Mackay graduated with a BS in Economics from the University of Pennsylvania’s Wharton School and an MBA from the Yale School of Management.

Positions